72 related articles for article (PubMed ID: 30527807)
1. A serine in exon 11 determines the full transcriptional activity of TCF-4 in lung carcinoma cells.
Yang B; Xu Y; Wang X; Liu Y
Biochem Biophys Res Commun; 2019 Jan; 508(3):675-681. PubMed ID: 30527807
[TBL] [Abstract][Full Text] [Related]
2. T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells.
Liu Y; Xu Y; Guo S; Chen H
Sci Rep; 2016 Apr; 6():24025. PubMed ID: 27046058
[TBL] [Abstract][Full Text] [Related]
3. Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.
Tomimaru Y; Xu CQ; Nambotin SB; Yan T; Wands JR; Kim M
Liver Int; 2013 Nov; 33(10):1536-48. PubMed ID: 23648141
[TBL] [Abstract][Full Text] [Related]
4. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
5. Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.
Koga H; Tsedensodnom O; Tomimaru Y; Walker EJ; Lee HC; Kim KM; Yano H; Wands JR; Kim M
PLoS One; 2012; 7(6):e39981. PubMed ID: 22768190
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
7. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
8. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
10. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing isoform of T cell factor 4K suppresses the proliferation and metastasis of non-small cell lung cancer cells.
Fan YC; Min L; Chen H; Liu YL
Genet Mol Res; 2015 Oct; 14(4):14009-18. PubMed ID: 26535715
[TBL] [Abstract][Full Text] [Related]
12. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
14. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
18. A unique DNA binding domain converts T-cell factors into strong Wnt effectors.
Atcha FA; Syed A; Wu B; Hoverter NP; Yokoyama NN; Ting JH; Munguia JE; Mangalam HJ; Marsh JL; Waterman ML
Mol Cell Biol; 2007 Dec; 27(23):8352-63. PubMed ID: 17893322
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
